Home
About
Overview
Sharing Data
ORCID
Help
History (1)
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents.
The randomized discontinuation trial: a phase II design to assess growth-inhibitory agents. Mol Cancer Ther. 2007 Apr; 6(4):1180-5.
View in:
PubMed
subject areas
Antineoplastic Agents
Clinical Trials, Phase II as Topic
Humans
Randomized Controlled Trials as Topic
authors with profiles
Walter M. Stadler